| Product Code: ETC13347198 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
Europe Precision Pathology Cancer Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Europe Precision Pathology Cancer Market Overview |
3.1 Europe Regional Macro Economic Indicators |
3.2 Europe Precision Pathology Cancer Market Revenues & Volume, 2021 & 2031F |
3.3 Europe Precision Pathology Cancer Market - Industry Life Cycle |
3.4 Europe Precision Pathology Cancer Market - Porter's Five Forces |
3.5 Europe Precision Pathology Cancer Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 Europe Precision Pathology Cancer Market Revenues & Volume Share, By Test Type, 2021 & 2031F |
3.7 Europe Precision Pathology Cancer Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F |
3.8 Europe Precision Pathology Cancer Market Revenues & Volume Share, By Technology Used, 2021 & 2031F |
3.9 Europe Precision Pathology Cancer Market Revenues & Volume Share, By Service Type, 2021 & 2031F |
4 Europe Precision Pathology Cancer Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Europe Precision Pathology Cancer Market Trends |
6 Europe Precision Pathology Cancer Market, 2021 - 2031 |
6.1 Europe Precision Pathology Cancer Market, Revenues & Volume, By Test Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Europe Precision Pathology Cancer Market, Revenues & Volume, By Biomarker Testing, 2021 - 2031 |
6.1.3 Europe Precision Pathology Cancer Market, Revenues & Volume, By Molecular Testing, 2021 - 2031 |
6.1.4 Europe Precision Pathology Cancer Market, Revenues & Volume, By Next-Generation Sequencing, 2021 - 2031 |
6.1.5 Europe Precision Pathology Cancer Market, Revenues & Volume, By Imaging Techniques, 2020 - 2028 |
6.2 Europe Precision Pathology Cancer Market, Revenues & Volume, By Cancer Type, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Europe Precision Pathology Cancer Market, Revenues & Volume, By Breast Cancer, 2021 - 2031 |
6.2.3 Europe Precision Pathology Cancer Market, Revenues & Volume, By Lung Cancer, 2021 - 2031 |
6.2.4 Europe Precision Pathology Cancer Market, Revenues & Volume, By Prostate Cancer, 2021 - 2031 |
6.2.5 Europe Precision Pathology Cancer Market, Revenues & Volume, By Colon Cancer, 2021 - 2031 |
6.3 Europe Precision Pathology Cancer Market, Revenues & Volume, By Technology Used, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Europe Precision Pathology Cancer Market, Revenues & Volume, By Digital Pathology, 2021 - 2031 |
6.3.3 Europe Precision Pathology Cancer Market, Revenues & Volume, By Immunohistochemistry, 2021 - 2031 |
6.3.4 Europe Precision Pathology Cancer Market, Revenues & Volume, By Whole Slide Imaging, 2021 - 2031 |
6.3.5 Europe Precision Pathology Cancer Market, Revenues & Volume, By Fluorescent In Situ Hybridization, 2021 - 2031 |
6.4 Europe Precision Pathology Cancer Market, Revenues & Volume, By Service Type, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Europe Precision Pathology Cancer Market, Revenues & Volume, By Diagnostic Services, 2021 - 2031 |
6.4.3 Europe Precision Pathology Cancer Market, Revenues & Volume, By Laboratory Services, 2021 - 2031 |
6.4.4 Europe Precision Pathology Cancer Market, Revenues & Volume, By In-House Testing, 2020 - 2028 |
6.4.5 Europe Precision Pathology Cancer Market, Revenues & Volume, By Third-Party Testing, 2020 - 2028 |
7 Europe Precision Pathology Cancer Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 Europe Precision Pathology Cancer Market, Revenues & Volume, By Test Type, 2021 - 2031 |
7.2.1 United Kingdom (UK) Precision Pathology Cancer Market, Revenues & Volume, By Test Type, 2021 - 2031 |
7.2.2 Germany Precision Pathology Cancer Market, Revenues & Volume, By Test Type, 2021 - 2031 |
7.2.3 France Precision Pathology Cancer Market, Revenues & Volume, By Test Type, 2021 - 2031 |
7.2.4 Poland Precision Pathology Cancer Market, Revenues & Volume, By Test Type, 2021 - 2031 |
7.2.5 Spain Precision Pathology Cancer Market, Revenues & Volume, By Test Type, 2021 - 2031 |
7.2.6 Rest of Europe Precision Pathology Cancer Market, Revenues & Volume, By Test Type, 2021 - 2031 |
7.3 Europe Precision Pathology Cancer Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F |
7.3.1 United Kingdom (UK) Precision Pathology Cancer Market, Revenues & Volume, By Cancer Type, 2021 - 2031 |
7.3.2 Germany Precision Pathology Cancer Market, Revenues & Volume, By Cancer Type, 2021 - 2031 |
7.3.3 France Precision Pathology Cancer Market, Revenues & Volume, By Cancer Type, 2021 - 2031 |
7.3.4 Poland Precision Pathology Cancer Market, Revenues & Volume, By Cancer Type, 2021 - 2031 |
7.3.5 Spain Precision Pathology Cancer Market, Revenues & Volume, By Cancer Type, 2021 - 2031 |
7.3.6 Rest of Europe Precision Pathology Cancer Market, Revenues & Volume, By Cancer Type, 2021 - 2031 |
7.4 Europe Precision Pathology Cancer Market, Revenues & Volume, By Technology Used, 2021 - 2031 |
7.4.1 United Kingdom (UK) Precision Pathology Cancer Market, Revenues & Volume, By Technology Used, 2021 - 2031 |
7.4.2 Germany Precision Pathology Cancer Market, Revenues & Volume, By Technology Used, 2021 - 2031 |
7.4.3 France Precision Pathology Cancer Market, Revenues & Volume, By Technology Used, 2021 - 2031 |
7.4.4 Poland Precision Pathology Cancer Market, Revenues & Volume, By Technology Used, 2021 - 2031 |
7.4.5 Spain Precision Pathology Cancer Market, Revenues & Volume, By Technology Used, 2021 - 2031 |
7.4.6 Rest of Europe Precision Pathology Cancer Market, Revenues & Volume, By Technology Used, 2021 - 2031 |
7.5 Europe Precision Pathology Cancer Market, Revenues & Volume, By Service Type, 2021 - 2031 |
7.5.1 United Kingdom (UK) Precision Pathology Cancer Market, Revenues & Volume, By Service Type, 2021 - 2031 |
7.5.2 Germany Precision Pathology Cancer Market, Revenues & Volume, By Service Type, 2021 - 2031 |
7.5.3 France Precision Pathology Cancer Market, Revenues & Volume, By Service Type, 2021 - 2031 |
7.5.4 Poland Precision Pathology Cancer Market, Revenues & Volume, By Service Type, 2021 - 2031 |
7.5.5 Spain Precision Pathology Cancer Market, Revenues & Volume, By Service Type, 2021 - 2031 |
7.5.6 Rest of Europe Precision Pathology Cancer Market, Revenues & Volume, By Service Type, 2021 - 2031 |
8 Europe Precision Pathology Cancer Market Key Performance Indicators |
9 Europe Precision Pathology Cancer Market - Export/Import By Countries Assessment |
10 Europe Precision Pathology Cancer Market - Opportunity Assessment |
10.1 Europe Precision Pathology Cancer Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 Europe Precision Pathology Cancer Market Opportunity Assessment, By Test Type, 2021 & 2031F |
10.3 Europe Precision Pathology Cancer Market Opportunity Assessment, By Cancer Type, 2021 & 2031F |
10.4 Europe Precision Pathology Cancer Market Opportunity Assessment, By Technology Used, 2021 & 2031F |
10.5 Europe Precision Pathology Cancer Market Opportunity Assessment, By Service Type, 2021 & 2031F |
11 Europe Precision Pathology Cancer Market - Competitive Landscape |
11.1 Europe Precision Pathology Cancer Market Revenue Share, By Companies, 2022 |
11.2 Europe Precision Pathology Cancer Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here